Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
Oncotarget
.
2020 Apr 21;11(16):1474-1477.
doi: 10.18632/oncotarget.27561.
Authors
Lihui Qu
#
1
2
3
4
,
Yingying Lu
#
1
2
3
4
,
Meike Ying
1
2
3
4
,
Bingjue Li
1
2
3
4
,
Chunhua Weng
1
2
3
4
,
Zhoutao Xie
1
2
3
4
,
Ludan Liang
1
2
3
4
,
Chuan Lin
1
2
3
4
,
Xian Yang
1
2
3
4
,
Shi Feng
1
2
3
4
,
Yucheng Wang
1
2
3
4
,
Xiujin Shen
1
2
3
4
,
Qin Zhou
1
2
3
4
,
Ying Chen
1
2
3
4
,
Zhimin Chen
1
2
3
4
,
Jianyong Wu
1
2
3
4
,
Weiqiang Lin
1
2
3
4
5
,
Yi Shen
6
,
Jing Qin
7
8
,
Hang Xu
7
,
Feng Xu
7
8
,
Junwen Wang
9
6
,
Jianghua Chen
1
2
3
4
,
Hong Jiang
1
2
3
4
,
Hongfeng Huang
1
2
3
4
Affiliations
1
Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
2
Kidney Disease Immunology Laboratory, The Third Grade Laboratory, State Administration of Traditional Chinese Medicine of PR China, Hangzhou, China.
3
Key Laboratory of Multiple Organ Transplantation, Ministry of Health, Hangzhou, China.
4
Key Laboratory of Nephropathy, Zhejiang Province, Hangzhou, China.
5
Institute of Translational Medicine, College of Medicine, Zhejiang University, Hangzhou, China.
6
Department of Epidemiology, College of Medicine, Zhejiang University, Hangzhou, China.
7
Department of Biochemistry, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
8
Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen, Guangdong, China.
9
Centre for Genomic Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
#
Contributed equally.
PMID:
32363004
PMCID:
PMC7185064
DOI:
10.18632/oncotarget.27561
Abstract
[This corrects the article DOI: 10.18632/oncotarget.18150.].
Copyright: © 2020 Qu et al.
Publication types
Published Erratum